Rosenberg David I.

DirectorPeak Bio, Inc. (PKBO) · full profile →Form 4 · filed Nov 3, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2022Other(J)77K$01.5M
Nov 1, 2022Option exercise(M)1.4M$01.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2022Conversion(C)1.4M$00
Nov 1, 2022Grant(A)2.5M$1.00$2.5M2.5M

Transaction Codes

J
Other acquisition / disposition
M
Option exercise / conversion
C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-035083) within minutes of acceptance. Every field above traces to the original document. Verify it directly: